Zimmermann B, Starke G, Shaw D, Elger B, Koné I. Actionability and scope should determine the extent of counselling for presymptomatic genetic testing. Swiss Med Wkly [Internet]. 2020 Jun. 29 [cited 2024 Apr. 15];150(2728):w20274. Available from: https://smw.ch/index.php/smw/article/view/2821